Tolvaptan in the very elderly with acute decompensated heart failure- a therapeutic option worthy of consideration

Ndrepepa, Gjin

Journal Metrics

Impact Factor (2022): 1.3
5-Year Impact Factor: 1.5
Eigenfactor Score: 0.00148
CiteScore (2022): 1.9
SCImago Journal Rank: 0.29

28/4Current Issue Ahead of Print Archive Most Accessed Articles

Quick Search

In authors and institutes

In titles and abstracts

In keywords

In all

pdf

Tolvaptan in the very elderly with acute decompensated heart failure- a therapeutic option worthy of consideration [Anatol J Cardiol]

Anatol J Cardiol. 2017; 18(3): 213-214 | DOI: 10.14744/AnatolJCardiol.2017.8033

Tolvaptan in the very elderly with acute decompensated heart failure- a therapeutic option worthy of consideration

Gjin Ndrepepa
Department of Adult Cardiology, Deutsches Herzzentrum München, Technical University; Munich-Germany

Gjin Ndrepepa. Tolvaptan in the very elderly with acute decompensated heart failure- a therapeutic option worthy of consideration. Anatol J Cardiol. 2017; 18(3): 213-214

Corresponding Author: Gjin Ndrepepa, Germany
Manuscript Language: English

TOOLS Full Text PDF Print Download citation RIS EndNote BibTex Medlars Procite Reference Manager Share with email Share Send email to author Similar articles PubMed Google Scholar